News/ News/ R&D PureTech to develop drug to treat lung scarring in COVID-19 patients Richard Staines coronavirus, COVID-19, PureTech. R&D, respiratory 0 Comment US biotech PureTech is to develop its most advanced pipeline drug LYT-100 as a potential treatment for inflammation and Share X PureTech to develop drug to treat lung scarring in COVID-19 patients https://pharmaphorum.com/news/puretech-to-develop-drug-to-treat-lung-scarring-in-covid-19-patients/
